These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31338907)
1. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells. Lindsay C; Kostiuk M; Conrad D; O'Connell DA; Harris J; Seikaly H; Biron VL Mol Carcinog; 2019 Nov; 58(11):1946-1959. PubMed ID: 31338907 [TBL] [Abstract][Full Text] [Related]
2. Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC. Song L; Xie H; Tong F; Yan B; Zhang S; Fu E; Jing Q; Wei L J Cell Biochem; 2019 Oct; 120(10):17438-17448. PubMed ID: 31119798 [TBL] [Abstract][Full Text] [Related]
3. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status. Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation. Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491 [TBL] [Abstract][Full Text] [Related]
6. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Du S; Liu K; Gao P; Li Z; Zheng J Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648 [TBL] [Abstract][Full Text] [Related]
7. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma. Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310 [TBL] [Abstract][Full Text] [Related]
8. Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. An Y; Jeon J; Sun L; Derakhshan A; Chen J; Carlson S; Cheng H; Silvin C; Yang X; Van Waes C; Chen Z Sci Rep; 2021 Mar; 11(1):6392. PubMed ID: 33737574 [TBL] [Abstract][Full Text] [Related]
9. HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma. Fleming JC; Woo J; Moutasim K; Mellone M; Frampton SJ; Mead A; Ahmed W; Wood O; Robinson H; Ward M; Woelk CH; Ottensmeier CH; King E; Kim D; Blaydes JP; Thomas GJ Br J Cancer; 2019 Feb; 120(3):356-367. PubMed ID: 30655616 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas. Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma. Broutian TR; Jiang B; Li J; Akagi K; Gui S; Zhou Z; Xiao W; Symer DE; Gillison ML Cancer Lett; 2020 Apr; 476():23-33. PubMed ID: 31958486 [TBL] [Abstract][Full Text] [Related]
12. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV Xiao R; An Y; Ye W; Derakhshan A; Cheng H; Yang X; Allen C; Chen Z; Schmitt NC; Van Waes C Clin Cancer Res; 2019 Nov; 25(21):6463-6474. PubMed ID: 31266830 [TBL] [Abstract][Full Text] [Related]
13. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer. Biktasova A; Hajek M; Sewell A; Gary C; Bellinger G; Deshpande HA; Bhatia A; Burtness B; Judson B; Mehra S; Yarbrough WG; Issaeva N Clin Cancer Res; 2017 Dec; 23(23):7276-7287. PubMed ID: 28916527 [No Abstract] [Full Text] [Related]
14. Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma. Robinson AM; Rathore R; Redlich NJ; Adkins DR; VanArsdale T; Van Tine BA; Michel LS Cell Death Dis; 2019 Nov; 10(11):867. PubMed ID: 31727874 [TBL] [Abstract][Full Text] [Related]
15. ATR inhibition sensitizes HPV Leonard BC; Lee ED; Bhola NE; Li H; Sogaard KK; Bakkenist CJ; Grandis JR; Johnson DE Oral Oncol; 2019 Aug; 95():35-42. PubMed ID: 31345392 [TBL] [Abstract][Full Text] [Related]
16. The role of Glial cell derived neurotrophic factor in head and neck cancer. Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217 [TBL] [Abstract][Full Text] [Related]
17. Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. Madera D; Vitale-Cross L; Martin D; Schneider A; Molinolo AA; Gangane N; Carey TE; McHugh JB; Komarck CM; Walline HM; William WN; Seethala RR; Ferris RL; Gutkind JS Cancer Prev Res (Phila); 2015 Mar; 8(3):197-207. PubMed ID: 25681087 [TBL] [Abstract][Full Text] [Related]